Copart CEO exercises options and sells shares
Copart Inc. Chief Executive Officer Jeffrey Liaw reported option-related transactions dated July 28, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Copart Inc. Chief Executive Officer Jeffrey Liaw reported option-related transactions dated July 28, 2026. He exercised stock options to acquire 46,757 shares of common stock at strike prices of $6.78 and $8.70 per share, and sold 27,745 shares at $30.49 per share. The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. The exercised options came from 2017 and 2018 grants that vested 20% after one year and the remainder monthly over 48 months.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
Liaw Jeffrey
Role
Chief Executive Officer
Sold
27,745 shs ($846K)
Approx. gross sale proceeds
$846K
Approx. exercise cost
$400K
Share of Position Sold
21.8%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F2 | 3,591 | $0.00 | $0.00 |
| Exercise | Stock Option F3 | 43,166 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,591 | $6.78 | $24K |
| Exercise | Common Stock | 43,166 | $8.70 | $376K |
| Sale | Common Stock F1 | 27,745 | $30.49 | $846K |
Holdings After Transaction:
Stock Option — 178,718 contracts (Direct);
Common Stock — 99,641 shares (Direct)
Holdings Before and After:
Stock Option, 225,475 to 178,718 contracts (Direct);
Common Stock, 80,629 to 99,641 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
- F2. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
- F3. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
Key Figures
Shares sold: 27,745 shares
Sale price: $30.49 per share
Options exercised (shares): 46,757 shares
+5 more
8 metrics
Shares sold
27,745 shares
Common stock sale on 2026-07-28 at $30.49 per share
Sale price
$30.49 per share
Price for 27,745 common shares sold on 2026-07-28
Options exercised (shares)
46,757 shares
Total shares from option exercises reported in transaction summary
Option strike price 1
$6.78 per share
Conversion or exercise price for 3,591 underlying shares
Option strike price 2
$8.70 per share
Conversion or exercise price for 43,166 underlying shares
10b5-1 plan adoption date
April 15, 2025
Date CEO adopted trading plan covering the 27,745-share sale
Initial vesting percentage
20%
Portion of options vesting on first anniversary of 2017 and 2018 grants
Remaining vesting period
48 months
Remaining options vested monthly over 48 months after first anniversary
Key Terms
Rule 10b5-1 trading plan, Exercise or conversion of derivative security, vested, grant date
4 terms
Rule 10b5-1 trading plan regulatory
"occurred automatically pursuan to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Exercise or conversion of derivative security financial
"transaction code description: Exercise or conversion of derivative security"
vested financial
"Twenty percent (20%) of the options vested on the first anniversary"
grant date financial
"vested on the first anniversary of the grant date (October 10, 2017)"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Copart (CPRT) CEO Jeffrey Liaw report on July 28, 2026?
Jeffrey Liaw reported option exercises and a share sale dated July 28, 2026. He exercised options into common stock and sold 27,745 shares, reflecting a mix of acquisitions from exercises and a disposition through the sale.
What are the strike prices of the Copart (CPRT) options Jeffrey Liaw exercised?
The exercised stock options had strike prices of $6.78 and $8.70 per share. One grant dated from October 10, 2017 and the other from October 4, 2018, each vesting 20% after one year and the balance monthly over 48 months.
How did the Copart (CPRT) CEO’s stock options vest according to the filing?
For both reported grants, 20% of the options vested on the first anniversary of the grant date. The remaining 80% vested on a monthly basis over the subsequent 48 months, reflecting a long‑term, time‑based vesting structure for the awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
